Quick Takeaways
- MANCHESTER MANAGEMENT CO LLC filed SCHEDULE 13G/A for NEUROONE MEDICAL TECHNOLOGIES CORP Common Stock, $0.001 par value (NMTC).
- Disclosed ownership: 4.9%.
- Date of event: 31 Dec 2024.
Quoteable Key Fact
"MANCHESTER MANAGEMENT CO LLC disclosed 4.9% ownership in NEUROONE MEDICAL TECHNOLOGIES CORP Common Stock, $0.001 par value (NMTC) on 31 Dec 2024."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| MANCHESTER EXPLORER, L.P. | 4.1% | 1,333,333 | 0 | 1,333,333 | By: /s/ James E. Besser | James E. Besser, Managing Member of the General Partner | |
| MANCHESTER MANAGEMENT COMPANY, LLC | 4.6% | 1,499,999 | 0 | 1,499,999 | By: /s/ James E. Besser | James E. Besser, Managing Member | |
| MANCHESTER MANAGEMENT PR, LLC | 4.6% | 1,499,999 | 0 | 1,499,999 | By: /s/ James E. Besser | James E. Besser, Managing Member | |
| JAMES E. BESSER | 4.9% | 1,583,332 | 83,333 | 1,499,999 | By: /s/ James E. Besser | James E. Besser | |
| MORGAN C. FRANK | 4.4% | 1,416,666 | 83,333 | 1,333,333 | By: /s/ Morgan C. Frank | Morgan C. Frank |